Semax and Selank for ADHD: what the evidence actually shows

What did @its.that.girl.tash actually say?

The creator describes using two Russian-developed peptides, which she calls "C-Max" (Semax) and "salenct" (Selank), to manage ADHD symptoms and anxiety. Her core claims are specific: Semax helps with ADHD symptom management, Selank calms the mind and reduces anxiety, and taking Selank about an hour before bed supports sleep. She also notes that taking Semax too late in the day "can sometimes disrupt your sleep." She's careful to add it "doesn't fix it but it definitely helps," which is a more measured framing than most peptide content on TikTok. She's speaking from personal experience, not presenting clinical data, and she doesn't assign doses or claim these peptides cure ADHD. That matters when evaluating her claims.

Does the science back this up?

Partially, yes, though the evidence base is thin and mostly Russian in origin. Semax is a synthetic heptapeptide derived from ACTH(4-7) and was developed in Russia in the 1980s. It has demonstrated effects on brain-derived neurotrophic factor (BDNF) expression and dopaminergic activity in animal models, which is why people connect it to ADHD. A 2014 study by Dolotov et al. published in the Journal of Neurochemistry documented Semax's influence on BDNF in the rat brain. Selank is a synthetic analogue of tuftsin with documented anxiolytic properties in animal and limited human trials. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) found Selank reduced anxiety in patients with generalized anxiety disorder. Neither compound has completed large-scale, placebo-controlled trials in humans for ADHD specifically. The evidence is real but limited.

What did they get wrong (or right)?

She got a few things right. The claim that Semax may interfere with sleep when taken later in the day is plausible given its stimulatory effects on dopamine and norepinephrine pathways. The claim that Selank has calming properties is supported by existing anxiolytic data. Where the video falls short is the implicit suggestion that these effects translate cleanly to ADHD management in humans. ADHD is a complex neurodevelopmental condition, and neither Semax nor Selank has been studied in ADHD populations in rigorous clinical trials. Extrapolating from BDNF modulation in rats to "managing ADHD symptoms" in adults is a significant leap. She doesn't make outrageous claims, but the framing implies more clinical certainty than the evidence supports. She also doesn't address that neither peptide is FDA-approved and that sourcing and purity vary significantly in the compounded peptide market.

What should you actually know?

Both Semax and Selank are unregulated in the United States, meaning they are not FDA-approved for any condition. They exist in a legal gray area and are often sold as research chemicals. The quality, concentration, and sterility of these compounds vary by supplier, which is a real safety concern, not a minor footnote. Anyone considering these peptides should consult a licensed clinician who specializes in peptide therapy, not a TikTok comment section. If you have ADHD, there are well-studied, FDA-approved treatments available. These peptides may have a role in a broader wellness protocol, but they should not be positioned as primary ADHD interventions. The creator's lived experience is valid data for her own life. It is not clinical evidence for yours.